Pres 221103
Pres 221103
Pres 221103
1 Group overview 2
2 Property & Casualty 6
3 Life & Health 12
4 Investments 15
5 Target Matrix and Outlook 2022 18
Appendix 21
21,620 17,634
856 871
15,000 12,000 700 700
P&C R/I C/R: 99.2% L&H R/I EBIT: 441 m. Investments RoI: 2.9%
• Strong and diversified premium growth +27.6% • Moderate premium growth +6.6% (f/x adjusted +1.1%) • AuM at EUR 58.0 bn. (+3.2%), strong operating
(f/x adjusted +18.6%) • Strong underlying performance, particularly in cash flow offsets negative effects from asset
• Large losses of EUR 1,484 m. exceeding budget of Financial Solutions and Longevity valuation
EUR 1,079 m. (incl. EUR 276 m. for hurricane “Ian”) • EBIT impacted by • RoI from AuM 2.9%, above target of >2.5%
• Precautionary reserving related to war in Ukraine at
EUR 331 m. (1H/2022: EUR 316 m.) – declining Covid-19 mortality claims of EUR 228 m. • Ordinary investment income +30.1%, supported by
• Negative PYD for large losses partly offset by positive effect of EUR 97 m. from contribution from inflation-linked bonds, rising
• Covid-19: increased frequency of claims in Asia A&H extreme mortality retro cover reinvestment yields and real estate
business, partly offset by reserve releases in Credit – Negative effect from reinsurance derivative
(EUR -144 m.)
Figures in EUR millions, unless otherwise stated
49,002
3,770 47,629
42,197
1,513
3,018
1,649
2,509 429
2,225 39
919 994
515 941
850
692 736
821
390 1,686
1,269
935
627 709
2018 2019 2020 2021 2022 2018 2019 2020 2021 30.09.2022
Q1 Q2 Q3 Q4 Total
14,071
13,589 2,977
2,232
871
2,234 11,921 11,885
871
11,035
844 (693)
826
1,493 2,980
765 8,251
690 1,224
11,885 (5,035)
10,528 10,995
8,777 8,251
2018 2019 2020 2021 30.09.2022 Shareholders' Net Dividend Change in Currency Shareholders'
equity income payment unrealised translation equity
Shareholders' equity Non-controlling interests Hybrid Total 31.12.2021 gains/losses and other 30.09.2022
1 Group overview 2
2 Property & Casualty 6
3 Life & Health 12
4 Investments 15
5 Target Matrix and Outlook 2022 18
Appendix 21
Gross written premium 5,003 6,562 15,269 19,484 • GWP f/x-adjusted +18.6%, diversified growth from traditional and Structured
Reinsurance business
Net premium earned 4,229 5,742 12,076 15,562 • NPE f/x-adjusted +20.2%
• Net large losses of EUR 1,484 m. (9.5% of NPE) above budget of EUR 1,079 m.
Net underwriting result for Q1-3/2022
(64) 25 253 121
incl. funds withheld
Combined ratio • Precautionary reserving related to war in Ukraine at EUR 331 m.
101.5% 99.6% 97.9% 99.2% (1H/2022: 316 m.)
incl. interest on funds withheld
• Covid-19: increased frequency of claims in Asia accident & health business,
Net investment income from assets
387 340 957 993 partly offset by reserve releases in Credit, net negative impact of ~EUR 150 m.
under own management
• Negative PYD for large losses (e.g. Brazil drought (EUR 130 m.), Texas Freeze
Other income and expenses (40) (64) (148) (227)
and Malaysia Floods)
• Increase in net investment income principally due to strong ordinary investment
Operating profit/loss (EBIT) 283 301 1,061 887 income, supported by inflation linkers (EUR 301 m.)
• Other income and expenses mainly driven by negative currency effects
Tax ratio 43.7% 37.3% 26.1% 29.0%
2,649
2,127
1,790
1,722 1,595 1,667
1,497 1,484
1,250
1,127
956
846 850
662 724 578 559 714 573
478 627
426
2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 Q1-3/2022
Gross Net Large loss budget (net) Large loss budget YTD (net)
EMEA1) 99.5%
Regional
Americas1) 95.1%
markets
APAC1) 130.1%
Total 99.2%
1) All lines of Property & Casualty reinsurance except those stated separately; EMEA incl. CIS
1 Group overview 2
2 Property & Casualty 6
3 Life & Health 12
4 Investments 15
5 Target Matrix and Outlook 2022 18
Appendix 21
Gross written premium 2,152 2,347 6,350 6,767 • GWP f/x-adjusted +1.1%
• NPE f/x-adjusted +2.5%
Net premium earned 1,889 2,076 5,558 6,024
• Technical result includes declining Covid-19 losses of EUR 228 m. (Q1-3/2021
EUR 404 m.), thereof US: EUR 113 m.
Net underwriting result
(122) (41) (315) (177) • Ordinary investment income increased primarily due to higher contribution from
incl. funds withheld
fixed income
Net investment income from assets
under own management
61 29 185 229 • Fair value of financial instruments includes positive valuation effect of EUR
97 m. from extreme mortality cover and negative effect from reinsurance-related
Other income and expenses 102 120 351 389 derivative in UK (EUR -144 m.)
• Other income and expenses mainly driven by strong contribution from deposit
Operating profit/loss (EBIT) 41 108 220 441 accounted treaties of EUR 338 m. (Q1-3/2021: EUR 282 m.) and one-off
recapturing fee income of EUR 40 m.
EBIT margin 2.2% 5.2% 4.0% 7.3%
Stable quarter with a promising pipeline for the rest of the year
Q3/2022 new and pipeline business1)
New Pipeline
business business
• Business financing (Australia) – Financial Solutions • Business financing (USA) – Financial Solutions
• Reserve relief (USA) – Financial Solutions • Solvency relief (Germany, USA) – Financial Solutions
• Risk relief (Germany, UK) – Longevity • Risk relief (Canada, UK, USA) – Longevity
• Risk relief (Colombia, USA) – Mortality • Risk relief (Brazil, Canada, France, USA) – Mortality
• Risk relief (Australia, USA) – Morbidity • Risk relief (Germany, USA) – Morbidity
VNB
250
Actual VNB Annual min. target (in m. EUR)
1) Focus on most important deals and opportunities
1 Group overview 2
2 Property & Casualty 6
3 Life & Health 12
4 Investments 15
5 Target Matrix and Outlook 2022 18
Appendix 21
1) Economic view based on market values without outstanding commitments for Private Equity and Alternative Real Estate as well as fixed-income investments of EUR 1,951.0 m. (EUR 1,588.2 m.) as at 30 September 2022
2) Of which Pfandbriefe and Covered Bonds = 58.7%
3) Before real estate-specific costs. Economic view based on market values as at 30 September 2022
1 Group overview 2
2 Property & Casualty 6
3 Life & Health 12
4 Investments 15
5 Target Matrix and Outlook 2022 18
Appendix 21
xRoCA5) ≥ 2% n.a.
Life & Health reinsurance Gross premium growth3) ≥ 3% +1.1%
xRoCA5) ≥ 2% n.a.
1) After tax; risk-free: 5-year average return of 10-year German government bonds 2) According to our internal capital model and Solvency II requirements
3) Average annual growth at constant f/x rates 4) Average annual growth
5) Excess return (one-year economic profit in excess of the cost of capital) on allocated economic capital 6) Based on Solvency II principles; pre-tax reporting
• Group net income 2) at the lower end of the EUR 1.4 - 1.5 bn. range
• Special dividend if capitalisation exceeds capital requirements for future growth and profit
targets are achieved
1 Group overview 2
2 Property & Casualty 6
3 Life & Health 12
4 Investments 15
5 Target Matrix and Outlook 2022 18
Appendix 21
As at 30 September 2022
Others
12%
EUR • Modified duration of fixed-income mainly congruent with
CAD 26% liability- and capital-driven targets
3%
2.8 • GBP’s higher modified duration predominantly due to life
AUD
6% 4.5 business
6.1
4.2
GBP Modified
6% 5.1
duration of
portfolio
Modified duration
Q3/2022 4.8
2021 5.8
4.7 2020 5.8
2019 5.7
USD
47%
2018 4.8
IR calendar
Disclaimer
This presentation does not address the investment objectives or financial situation of any particular person or legal entity.
Investors should seek independent professional advice and perform their own analysis regarding the appropriateness of
investing in any of our securities.
While Hannover Re has endeavoured to include in this presentation information it believes to be reliable, complete and up-to-
date, the company does not make any representation or warranty, express or implied, as to the accuracy, completeness or
updated status of such information.
Some of the statements in this presentation may be forward-looking statements or statements of future expectations based on
currently available information. Such statements naturally are subject to risks and uncertainties. Factors such as the
development of general economic conditions, future market conditions, unusual catastrophic loss events, changes in the capital
markets and other circumstances may cause the actual events or results to be materially different from those anticipated by
such statements.
This presentation serves information purposes only and does not constitute or form part of an offer or solicitation to acquire,
subscribe to or dispose of, any of the securities of Hannover Re.